Literature DB >> 2409232

Demonstration and distribution of kassinin-like material (substance K) in the rat central nervous system.

C W Shults, H Yajima, H G Gullner, T N Chase, T L O'Donohue.   

Abstract

Antiserum was raised against kassinin in rabbits. Cross-reactivity with other tachykinins was determined; these included substance K (100%) and substance P (0.1%). Peptides extracted from rat brain and synthetic tachykinins were chromatographed by reverse-phase HPLC. The major peak of kassinin-like material eluted at a time different from that of synthetic kassinin, eledoisin, physalaemin, neurokinin beta, and substance P but coeluted with substance K. Measurement of kassinin-like material in macrodissected and microdissected brain regions indicated that the distribution of kassinin-like material was similar to that of substance P.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2409232     DOI: 10.1111/j.1471-4159.1985.tb04023.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  4 in total

Review 1.  Organization and physiology of the substantia nigra.

Authors:  H Condé
Journal:  Exp Brain Res       Date:  1992       Impact factor: 1.972

2.  Striato-nigral dynorphin and substance P pathways in the rat. II. Functional analysis.

Authors:  M Herrera-Marschitz; I Christensson-Nylander; T Sharp; W Staines; M Reid; T Hökfelt; L Terenius; U Ungerstedt
Journal:  Exp Brain Res       Date:  1986       Impact factor: 1.972

3.  Neuropeptide gene expression in brain is differentially regulated by midbrain dopamine neurons.

Authors:  N Lindefors; S Brené; M Herrera-Marschitz; H Persson
Journal:  Exp Brain Res       Date:  1990       Impact factor: 1.972

4.  Mapping of neurokinin-like immunoreactivity in the human brainstem.

Authors:  Rafael Coveñas; Francisco Martin; Magdalena Belda; Victor Smith; Pablo Salinas; Eva Rivada; Zaida Diaz-Cabiale; Jose Angel Narvaez; Pilar Marcos; Gerard Tramu; Salvador Gonzalez-Baron
Journal:  BMC Neurosci       Date:  2003-02-04       Impact factor: 3.288

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.